Bend Research is expanding its commercial spray-dried dispersion (SDD) manufacturing with capital from new owners Capsugel in order to offer unique integrated capabilities, the firm says.
Dow says the acquisition of partner Bend Research is “good news” and will strengthen its developments in solving solubility and bioavailability issues in drug formulation.
Bend Research, the Oregon US-based drug manufacturer, has received a new US patent covering the use of polymer additives to help increase the efficacy of low-solubility drugs.
US formulation services provider Bend Research has received a new patent for the process of producing spray-dried solid amorphous dispersions of drugs using single-fluid pressure nozzles.